Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ (942,808)	$ (470,551)
Depreciation and amortization	308,084	376,920
Operating cash flows from operating leases	248,757
Amortization of deferred gain on sale/leaseback	(27,474)	(28,486)
Provision for losses on accounts receivable	6,085	(17,781)
Provision for losses on inventories	(10,656)	(35,503)
Deferred income taxes	(360,492)	(133,982)
Change in assets and liabilities:
Accounts receivable	249,950	(465,865)
Inventories	(827,084)	(1,995,477)
Prepaid expenses and other assets	(235,701)	109,567
Trade payables	1,971,593	1,572,804
Accrued liabilities	(149,957)	127,038
Net cash provided by (used in) operating activities	230,297	(961,316)
Cash flows from investing activities:
Purchases of property, plant and equipment	(52,243)	63,533
Net cash provided by (used in) investing activities	(52,243)	63,533
Cash flows from financing activities:
Change in checks written in excess of bank balance	18,504	(442,992)
Net change in revolving line of credit	(1,235,126)	2,123,582
Repayment of long-term debt	771,113	(432,942)
Proceeds from issuance of stock	28,967	61,975
Cash paid for deferred financing fees	3,800	(24,568)
Net cash provided by (used in) financing activities	(412,742)	1,285,055
Effect of exchange rate changes on cash	(18,020)	27,307
Net increase/(decrease) in cash and cash equivalents	(252,708)	414,579
Cash and cash equivalents at beginning of period	428,150	181,026
Cash and cash equivalents at end of period	175,442	595,605
Supplemental disclosure of cash flow information:
Cash payments for interest	366,688	408,001
Supplemental Disclosure of non-cash investing and financing activity
Property, Plant & Equipment acquisitions funded by liabilities	$ 11,869	$ 25,387